JP6766034B2 - 薬剤送達システム及び方法 - Google Patents
薬剤送達システム及び方法 Download PDFInfo
- Publication number
- JP6766034B2 JP6766034B2 JP2017513411A JP2017513411A JP6766034B2 JP 6766034 B2 JP6766034 B2 JP 6766034B2 JP 2017513411 A JP2017513411 A JP 2017513411A JP 2017513411 A JP2017513411 A JP 2017513411A JP 6766034 B2 JP6766034 B2 JP 6766034B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- sensor circuit
- transmission hub
- application
- information
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012377 drug delivery Methods 0.000 title claims description 47
- 238000000034 method Methods 0.000 title claims description 30
- 229940079593 drug Drugs 0.000 claims description 201
- 239000003814 drug Substances 0.000 claims description 201
- 230000005540 biological transmission Effects 0.000 claims description 106
- 238000001514 detection method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 2
- 230000015654 memory Effects 0.000 description 15
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 11
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 238000004806 packaging method and process Methods 0.000 description 7
- 238000012384 transportation and delivery Methods 0.000 description 7
- 229930182837 (R)-adrenaline Natural products 0.000 description 6
- 238000004891 communication Methods 0.000 description 6
- 229960005139 epinephrine Drugs 0.000 description 6
- 229940015979 epipen Drugs 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 108010072051 Glatiramer Acetate Proteins 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229940112141 dry powder inhaler Drugs 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002483 medication Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- UZHSEJADLWPNLE-GRGSLBFTSA-N naloxone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4CC=C UZHSEJADLWPNLE-GRGSLBFTSA-N 0.000 description 3
- 229960004127 naloxone Drugs 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- FHEAIOHRHQGZPC-KIWGSFCNSA-N acetic acid;(2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-aminopentanedioic acid;(2s)-2-aminopropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound CC(O)=O.C[C@H](N)C(O)=O.NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 FHEAIOHRHQGZPC-KIWGSFCNSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229940038717 copaxone Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 229960003776 glatiramer acetate Drugs 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 229940071648 metered dose inhaler Drugs 0.000 description 2
- 238000012015 optical character recognition Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 230000005355 Hall effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960002964 adalimumab Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940048921 humira Drugs 0.000 description 1
- 229940127560 insulin pen Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- ORQBXQOJMQIAOY-UHFFFAOYSA-N nobelium Chemical compound [No] ORQBXQOJMQIAOY-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 230000008054 signal transmission Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Treatment And Welfare Office Work (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/483,572 US9692829B2 (en) | 2012-12-03 | 2014-09-11 | Medication delivery system and method |
US14/483,572 | 2014-09-11 | ||
PCT/US2015/049232 WO2016040512A1 (en) | 2014-09-11 | 2015-09-09 | Medication delivery system and method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019216502A Division JP2020053078A (ja) | 2014-09-11 | 2019-11-29 | 薬剤送達システム及び方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017529920A JP2017529920A (ja) | 2017-10-12 |
JP6766034B2 true JP6766034B2 (ja) | 2020-10-07 |
Family
ID=55459534
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017513411A Expired - Fee Related JP6766034B2 (ja) | 2014-09-11 | 2015-09-09 | 薬剤送達システム及び方法 |
JP2019216502A Pending JP2020053078A (ja) | 2014-09-11 | 2019-11-29 | 薬剤送達システム及び方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019216502A Pending JP2020053078A (ja) | 2014-09-11 | 2019-11-29 | 薬剤送達システム及び方法 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP3191972A4 (de) |
JP (2) | JP6766034B2 (de) |
CN (1) | CN107077451A (de) |
AU (1) | AU2015315181A1 (de) |
CA (1) | CA2960519A1 (de) |
RU (1) | RU2017107745A (de) |
WO (1) | WO2016040512A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9692829B2 (en) | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
US20140155827A1 (en) | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
WO2017212473A2 (en) | 2016-06-06 | 2017-12-14 | E3D Agricultural Cooperative Association Ltd | Multiple use computerized injector |
US11730879B2 (en) | 2017-12-28 | 2023-08-22 | Sanofi | Packaging assembly |
CA3155571A1 (en) * | 2019-09-25 | 2021-04-01 | Janssen Pharmaceuticals, Inc. | Drug delivery systems and methods |
JP2022549330A (ja) * | 2019-09-25 | 2022-11-24 | ヤンセン ファーマシューティカルズ,インコーポレーテッド | 薬物投与システムの相互接続 |
KR20220088703A (ko) * | 2019-09-25 | 2022-06-28 | 얀센 파마슈티칼즈, 인코포레이티드 | 약물 전달 조정 |
CA3156032A1 (en) * | 2019-09-25 | 2021-04-01 | Janssen Pharmaceuticals, Inc. | MEASUREMENT OF PARAMETERS ASSOCIATED WITH DRUG DELIVERY AND DRUG DELIVERY DEVICES COMPRISING THE SAME |
WO2023084479A2 (en) * | 2021-11-15 | 2023-05-19 | Tech Pharmacy Services, Llc | Cyber protection for pharmaceutical dispensing systems |
CN114053071A (zh) * | 2021-11-16 | 2022-02-18 | 中国医学科学院肿瘤医院深圳医院 | 一种智能护理工作台 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002152309A (ja) * | 2000-11-15 | 2002-05-24 | Sharp Corp | Bluetooth機器 |
JP3308972B1 (ja) * | 2001-01-16 | 2002-07-29 | 有限会社セルフセキュリティ | 服薬確認支援装置 |
JP2004280455A (ja) * | 2003-03-14 | 2004-10-07 | Toshiba Corp | 医療情報システム |
US20040210488A1 (en) * | 2003-04-17 | 2004-10-21 | Doherty James M. | Internet Pharmacy Dispenser |
KR100906176B1 (ko) * | 2003-11-25 | 2009-07-03 | 인터내셔널 비지네스 머신즈 코포레이션 | 모바일 허브 및 모바일 허브에서의 이벤트 관리 방법 |
US8361026B2 (en) * | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
US8126733B2 (en) * | 2006-10-24 | 2012-02-28 | Medapps, Inc. | Systems and methods for medical data interchange using mobile computing devices |
JPWO2008117544A1 (ja) * | 2007-03-28 | 2010-07-15 | 日本電気株式会社 | 内包物管理デバイス、内包物管理デバイス製造装置、内包物管理デバイス製造方法、及び内包物管理方法 |
US9550031B2 (en) * | 2008-02-01 | 2017-01-24 | Reciprocal Labs Corporation | Device and method to monitor, track, map, and analyze usage of metered-dose inhalers in real-time |
JP2009258941A (ja) * | 2008-04-16 | 2009-11-05 | Tokyo Institute Of Technology | 治験データ収集システム |
US9089650B2 (en) * | 2008-10-01 | 2015-07-28 | Novo Nordisk A/S | Medical assembly with monitoring device |
US8716667B2 (en) * | 2009-04-06 | 2014-05-06 | Sony Corporation | Switching apparatus, switching method, and electronic device |
WO2010132617A2 (en) * | 2009-05-12 | 2010-11-18 | Chronicmobile, Inc. | Methods and systems for managing, controlling and monitoring medical devices via one or more software applications functioning in a secure environment |
US20110021140A1 (en) * | 2009-07-22 | 2011-01-27 | Boston Life Labs | Method and apparatus for providing home healthcare services using a sensor network |
WO2012145004A1 (en) * | 2011-04-21 | 2012-10-26 | Empire Technology Development Llc | Locative social networking using a mobile device |
US20130246083A1 (en) * | 2012-03-16 | 2013-09-19 | Alexion Pharmaceuticals, Inc. | Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor |
US20130262184A1 (en) * | 2012-03-30 | 2013-10-03 | Arbitron Inc. | Systems and Methods for Presence Detection and Linking to Media Exposure Data |
JP2015514483A (ja) * | 2012-04-17 | 2015-05-21 | ノボ・ノルデイスク・エー/エス | レジメン特定フィーチャを伴う医療用送達装置 |
US9049998B2 (en) * | 2012-06-22 | 2015-06-09 | Fitbit, Inc. | Biometric monitoring device with heart rate measurement activated by a single user-gesture |
US8768673B2 (en) * | 2012-07-26 | 2014-07-01 | Rimidi Diabetes, Inc. | Computer-implemented system and method for improving glucose management through cloud-based modeling of circadian profiles |
US9196139B2 (en) * | 2012-09-12 | 2015-11-24 | ACCO Brands Corporation | Proximity tag for object tracking |
JP6021105B2 (ja) * | 2012-10-19 | 2016-11-02 | 株式会社プロップ | 服薬管理システム |
US20140155827A1 (en) * | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
US9692829B2 (en) * | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
-
2015
- 2015-09-09 RU RU2017107745A patent/RU2017107745A/ru not_active Application Discontinuation
- 2015-09-09 WO PCT/US2015/049232 patent/WO2016040512A1/en active Application Filing
- 2015-09-09 CN CN201580048532.5A patent/CN107077451A/zh active Pending
- 2015-09-09 AU AU2015315181A patent/AU2015315181A1/en not_active Abandoned
- 2015-09-09 CA CA2960519A patent/CA2960519A1/en not_active Abandoned
- 2015-09-09 JP JP2017513411A patent/JP6766034B2/ja not_active Expired - Fee Related
- 2015-09-09 EP EP15840938.3A patent/EP3191972A4/de not_active Ceased
-
2019
- 2019-11-29 JP JP2019216502A patent/JP2020053078A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
RU2017107745A (ru) | 2018-10-11 |
CA2960519A1 (en) | 2016-03-17 |
WO2016040512A1 (en) | 2016-03-17 |
JP2017529920A (ja) | 2017-10-12 |
CN107077451A (zh) | 2017-08-18 |
JP2020053078A (ja) | 2020-04-02 |
EP3191972A4 (de) | 2018-03-14 |
EP3191972A1 (de) | 2017-07-19 |
AU2015315181A1 (en) | 2017-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9807174B2 (en) | Medication delivery system and method | |
JP6766034B2 (ja) | 薬剤送達システム及び方法 | |
US10347375B2 (en) | Automatic association of medical elements | |
US11011260B2 (en) | Medication management and reporting technology | |
CN107111687A (zh) | 使用连接的物理设备以及其间的数据传输进行应用解锁 | |
CN107111677A (zh) | 连接护理提供者的可佩戴物 | |
US20170024542A1 (en) | Logging system and a method of registering data for enabling monitoring of intake of a product by a user according to an intake plan | |
US20220280391A1 (en) | Medication dispensing machine and system | |
EP2973368B1 (de) | Kontextbewusstes gesundheitsversorgungs-benachrichtigungssystem | |
TWI599982B (zh) | Ibeacon dementia elderly care communication method and system | |
TWI686191B (zh) | 群組式用藥提醒系統 | |
US20240189185A1 (en) | Locking cap assembly | |
TR201604967A2 (tr) | Akilli i̇laç kutusu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180910 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190924 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191001 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200114 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200410 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200818 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200916 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6766034 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |